Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cells in cardiac repair.

Nicholas F Grigoropoulos1, Anthony Mathur

  • 1Cardiac Research Department, The London Chest Hospital, Bonner Road, London E2 9JX, UK.

Current Opinion in Pharmacology
|February 18, 2006
PubMed
Summary

Adult progenitor cell therapy shows promise for treating heart failure after acute myocardial infarction. Early clinical trials indicate safety and potential for cardiac function improvement, with larger studies ongoing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Narrowing sex differences in pharmacotherapy following invasive angiography for coronary artery disease between 2017 and 2024.

European heart journal open·2026
Same author

Computational modelling for personalized transcatheter aortic valve replacement planning: a systematic review of complications and decision support.

Frontiers in digital health·2026
Same author

Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Cardiogenic Shock: Clinical Management, Outcomes and Future Directions.

Journal of cardiovascular development and disease·2026
Same author

A randomized crossover clinical trial comparing 24-h blood pressure measurements from two different cuffless wrist ambulatory monitors with cuffed ambulatory monitoring for translation to clinical practice: Rationale and Design of Continuum BP study.

American heart journal plus : cardiology research and practice·2026
Same author

Angiography-derived fractional flow reserve- vs usual care-guided percutaneous coronary intervention: interim analysis of the PIONEER IV trial.

European heart journal·2026

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cell Therapy

Background:

  • Advances in acute myocardial infarction treatment increase survival but raise heart failure incidence.
  • Adult progenitor cell therapy, particularly using bone marrow-derived cells, shows potential for improving cardiac function in animal models.
  • The precise mechanisms underlying cell therapy's efficacy remain under investigation.

Purpose of the Study:

  • To evaluate the safety and efficacy of adult progenitor cell therapy in patients with heart failure post-acute myocardial infarction.
  • To explore different cell subpopulations and delivery routes for autologous cell transplantation.
  • To assess the clinical impact of cell therapy in early-phase human trials.

Main Methods:

  • Utilized autologous cell subpopulations for transplantation in human subjects.
  • Administered cells via various delivery routes to infarcted cardiac regions.
  • Conducted small-scale Phase I clinical trials to assess safety and preliminary efficacy.

Main Results:

  • Phase I trials demonstrated the safety of adult progenitor cell therapy in this patient population.
  • Preliminary clinical improvements in cardiac function were observed post-treatment.
  • Larger randomized controlled studies are currently in progress to confirm these findings.

Conclusions:

  • Adult progenitor cell therapy is a potentially safe and effective treatment for heart failure following acute myocardial infarction.
  • Cell therapy represents a promising new therapeutic strategy for cardiovascular diseases.
  • Further research through large-scale randomized trials is warranted to establish definitive clinical benefits.

Related Experiment Videos